Recombinant biologics for treatment of bleeding di...[Nat Rev Drug Discov. 2004] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Click to change filter selection through MyNCBI.

1: Nat Rev Drug Discov. 2004 Aug;3(8):684-94. Links

Recombinant biologics for treatment of bleeding disorders.

Bishop P, Lawson J.

ZymoGenetics, Inc., 1201 Eastlake Avenue East, Seattle, Washington 98102, USA. bishopp@zgi.com

PMID: 15286735 [PubMed - indexed for MEDLINE]

Related articles

Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
Blood Coagul Fibrinolysis. 2008 Jun; 19(4):327-8.

[Blood Coagul Fibrinolysis. 2008]
Review[Recombinant blood coagulation factors]
Pharm Unserer Zeit. 2006; 35(1):40-5.

[Pharm Unserer Zeit. 2006]
Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
J Am Board Fam Pract. 2003 Nov-Dec; 16(6):549-52.

[J Am Board Fam Pract. 2003]
Optimal treatment regimens for patients with bleeding disorders.
Haemophilia. 2001 May; 7(3):313-20.

[Haemophilia. 2001]
Review"Off-license" use of recombinant activated factor VII.
Blood Rev. 2004 Dec; 18(4):245-59.

[Blood Rev. 2004]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Recombinant biologics for treatment of bleeding disorders.Recombinant biologics for treatment of bleeding disorders.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show